Skip to main content
# Title Department Research Member Research Year
641 Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2018
642 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Department of Pediatric Oncology Dr. Shaimaa / Elsayyed Youssef / Ahmed 2018
643 Effect of Intrathecally Administered Ketamine, Morphine, and Their Combination Added to Bupivacaine in Patients Undergoing Major Abdominal Cancer Surgery a Randomized, Double-Blind Study Department of Anesthesia, Intensive care and Pain management Prof. Ashraf Amin Mohamed 2018
644 New Look on Ureterocolic Diversion with Adjuvant Radiotherapy; SECI (South Egypt Cancer Institute) Experience Department of Surgical Oncology Dr. Ebraheem Abuelouoon Gaber Ali 2018
645 Telomere dysfunction-related serological markers and oxidative stress markers in rheumatoid arthritis patients: correlation with diseases activity Department of Clinical Pathology Dr. Mohamed Galal Mostafa ELnaggar 2018
646 Effect of Intrathecally Administered Ketamine, Morphine, and Their Combination Added to Bupivacaine in Patients Undergoing Major Abdominal Cancer Surgery a Randomized, Double-Blind Study Department of Anesthesia, Intensive care and Pain management Dr. Ahmad Mohammad Abd El-Rahman 2018
647 Signet ring carcinoma of the stomach: impact on prognosis and outcome
Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2018
648 HCMV Among Pediatrics Acute Lymphoblastic Leukemia Patients in South Egypt Cancer Institute Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2018
649 comparison between frequency ablation and chemical neurolysis of thoracic plainchant nerves for the management of abdominal cancer pain , randomized trial Department of Anesthesia, Intensive care and Pain management Prof. Samy Abdel Rahman Amr Erfan 2018
650 Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2018